Last reviewed · How we verify

NCT03780400

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP)

Completed NA Results posted Last updated 25 August 2020
What this trial tests

NA trial testing Osteoarthritis Physical Activity Care Pathway in Osteoarthritis in 60 participants. Completed in 31 December 2019.

Timeline
21 March 2019
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorUniversity of North Carolina, Chapel Hill
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date21 March 2019
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of North Carolina, Chapel Hill

Who can join

65 and older, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change From Baseline to Month 4 for Minutes of Moderate to Vigorous Intensity PA Per Week Primary · Baseline, Month 4 (Follow-up)

Minutes of moderate to vigorous intensity physical activity (MVPA) per week measured via accelerometer

GroupValue95% CI
OA-PCP0.78-1.6 – 3.2
Change From Baseline to Month 4 for Steps Per Day Secondary · Baseline, Month 4 (Follow-up)

Step counts were measured via an accelerometer device.

GroupValue95% CI
OA-PCP143.7-174.9 – 462.2
Change From Baseline to Month 4 for Minutes of Sedentary Activity Secondary · Baseline, Month 4 (Follow-up)

Minutes of sedentary activity were measured via an accelerometer device.

GroupValue95% CI
OA-PCP-0.15-17.0 – 16.7
Change From Baseline to Month 4 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Function Subscale Secondary · Baseline, Month 4 (Follow-up)

The Western Ontario and McMasters Universities Osteoarthritis (WOMAC) function subscale includes 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty), with ranges of 0-68 for the function subscale with higher scores indicating worse symptoms and function.

GroupValue95% CI
OA-PCP-6.1-8.7 – -3.4
Change From Baseline to Month 4 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Pain Subscale Secondary · Baseline, Month 4 (Follow-up)

The Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Pain Subscale is a measure of lower extremity pain. It includes 5 items rated on a Likert scale of 0 (no pain) to 4 (extreme pain), with a total range of 0-20 with higher scores indicating worse symptoms and function.

GroupValue95% CI
OA-PCP-1.9-2.7 – -1.0

Sponsor's own description

This is a multi-phase study that will develop and test an osteoarthritis (OA) primary care Physical activity Care Pathway (OA-PCP), a scalable intervention that includes: 1) a practical process for physical inactivity screening in primary care, 2) a brief, tailored physical activity (PA) counseling intervention via telephone, 3) connection of patients with community programs and other resources to support PA, and 4) follow-up with patients to deliver additional appropriate counseling and referrals to PA resources.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Osteoarthritis physical activity care pathway (OA-PCP): results of a feasibility trial.
    Allen K, Vu MB, Callahan LF, Cleveland RJ, et al · · 2020 · cited 9× · PMID 32416715 · DOI 10.1186/s12891-020-03339-6
  2. Accelerometer-Based Physical Activity Patterns and Associations With Outcomes Among Individuals With Osteoarthritis.
    Beauchamp T, Arbeeva L, Cleveland RJ, Golightly YM, et al · · 2022 · cited 6× · PMID 33902099 · DOI 10.1097/rhu.0000000000001750

Verify or expand the search:

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing